Comparative study between quantitative digital image analysis and fluorescence in situ hybridization of breast cancer equivocal human epidermal growth factor receptors 2 score 2+ cases
Authors:
Open Access
- 1 January 2015
- journal article
- Published by Elsevier in Journal of Pathology Informatics
- Vol. 6 (1) , 31
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Reproducibility in the automated quantitative assessment of HER2/neu for breast cancerJournal of Pathology Informatics, 2013
- Image Analysis of HER2 Immunohistochemical StainingAmerican Journal of Clinical Pathology, 2012
- Image analysis as an adjunct to manual HER‐2 immunohistochemical review: a diagnostic tool to standardize interpretationHistopathology, 2010
- How to Treat Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Amplified Breast CancerJournal of Clinical Oncology, 2009
- Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patientsCancer, 2009
- Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situhybridization (FISH): pathologist assessment compared to quantitative image analysisBMC Cancer, 2009
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in‐situ hybridization in the evaluation of HER‐2/neu expression in primary breast carcinomaHistopathology, 2005
- Enhanced Accuracy and Reliability of HER-2/neuImmunohistochemical Scoring Using Digital MicroscopyAmerican Journal of Clinical Pathology, 2004
- Enhanced Accuracy and Reliability of HER-2/neu Immunohistochemical Scoring Using Digital MicroscopyAmerican Journal of Clinical Pathology, 2004